Effect of zinc on [3H]-QNB displacement by cholinergic agonists and antagonists.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001667:Binding, Competitive; D008297:Male; D010095:Oxotremorine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D010862:Pilocarpine / Q000494:pharmacology; D011812:Quinuclidines / Q000378:metabolism*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism*; D051381:Rats; D015032:Zinc / Q000494:pharmacology*
D010276:Parasympatholytics; D010277:Parasympathomimetics; D011812:Quinuclidines; D010862:Pilocarpine; D001115:Arecoline; D010095:Oxotremorine; D011813:Quinuclidinyl Benzilate; D001285:Atropine; D010830:Physostigmine; D015032:Zinc; D000109:Acetylcholine